MPR Weekly Dose #67 - Efficacy data for AstraZeneca, J&J and Novovax vaccines; Approvals in analgesia and influenza.

<p><span style="font-weight: 400;">This week we take a look at the remaining prospective COVID vaccines, that includes AstraZeneca, J&J and Novovax; There’s also drug approvals for analgesia and influenza.</span></p>